Mirae Asset Global Investments Co., Ltd. Belite Bio, Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Belite Bio, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 357 shares of BLTE stock, worth $20,688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
357Holding current value
$20,688% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLTE
# of Institutions
18Shares Held
80.3KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA20.1KShares$1.16 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC13.5KShares$779,4850.0% of portfolio
-
Marshall Wace, LLP London, X08.49KShares$491,7630.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.7KShares$388,2650.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.46KShares$374,3570.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.44B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...